CMS Withdraws Memorandum, Seeks Public Comment on Blood Glucose Monitoring

The Centers for Medicare & Medicaid Services (CMS) has backed off on some of its CLIA mandates regarding blood glucose monitoring systems (BGMS) for off-label use. CMS issued a memorandum in November 2014 addressing point-of-care use of BGMS, which it has now withdrawn, revised and re-issued in draft form for public comment. That memorandum pertained…